Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

Join our Community Webinar!

20 October 2022

Join our Community Webinar on November 16, 2022 (7 - 8 p.m.) to learn more about BWXT Medical’s operations in Kanata, Ontario.



Facility Familiarization Visit with Ottawa Fire Services: Friday, September 23, 2022

22 September 2022

On Friday, September 23, 2022, Ottawa Fire Services will be onsite at BWXT Medical’s Kanata facility on 447 March Road for a facility familiarization visit.


BWXT Medical Submits Tc-99m Generator New Drug Application to FDA

13 September 2022

BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for diagnostic imaging.


BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products

27 June 2022

(OTTAWA, ON – June 27, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225).